New PIP Court Ruling Sends Further Shockwaves Through EU Medtech Sector
Executive Summary
Notified bodies in the EU medtech sector have reason to feel nervous: recipients of the fraudulently manufactured PIP breast implants have had yet more court success in a case that is challenging the liability status of notified bodies at a critical time for EU regulation. But the final say is still awaited.